Clinical Trial Update: Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia

View source ↗

Summary

A clinical trial evaluated ALNA (tamsulosin) for the primary symptoms of benign prostatic hyperplasia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• ALNA (tamsulosin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Prostatic Hyperplasia | Status: COMPLETED